A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Public ClinicalTrials.gov record NCT07277660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT07277660
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- Galvokimig Biological
- Placebo Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 28, 2025
- Primary completion
- May 16, 2027
- Completion
- Mar 5, 2028
- Last update posted
- May 7, 2026
2025 – 2028
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Atd002 52021 | Oceanside | California | 92056 | Recruiting |
| Atd002 52008 | Santa Monica | California | 90404 | Recruiting |
| Atd002 52013 | Boca Raton | Florida | 33486 | Recruiting |
| Atd002 52007 | Coral Gables | Florida | 33134 | Recruiting |
| Atd002 52003 | Miami | Florida | 33133 | Recruiting |
| Atd002 52015 | Savannah | Georgia | 31419 | Recruiting |
| Atd002 52017 | Chicago | Illinois | 60611 | Recruiting |
| Atd002 52018 | Wheaton | Illinois | 60189 | Recruiting |
| Atd002 52012 | New Albany | Indiana | 47150 | Recruiting |
| Atd002 52014 | Bowling Green | Kentucky | 42104 | Recruiting |
| Atd002 52001 | Troy | Michigan | 48084 | Recruiting |
| Atd002 52009 | Troy | Michigan | 48084 | Recruiting |
| Atd002 52010 | Omaha | Nebraska | 68144 | Recruiting |
| Atd002 52020 | The Bronx | New York | 10455 | Recruiting |
| Atd002 52019 | Philadelphia | Pennsylvania | 19114 | Recruiting |
| Atd002 52005 | Dallas | Texas | 75230 | Recruiting |
| Atd002 52016 | Frisco | Texas | 75033 | Recruiting |
| Atd002 52011 | Frisco | Texas | 75034 | Recruiting |
| Atd002 52004 | Sugar Land | Texas | 77479 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07277660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07277660 live on ClinicalTrials.gov.